TY - JOUR
T1 - Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
AU - Xie, Yan
AU - Bowe, Benjamin
AU - Mokdad, Ali H.
AU - Xian, Hong
AU - Yan, Yan
AU - Li, Tingting
AU - Maddukuri, Geetha
AU - Tsai, Cheng You
AU - Floyd, Tasheia
AU - Al-Aly, Ziyad
N1 - Publisher Copyright:
© 2018
PY - 2018/9
Y1 - 2018/9
N2 - The last quarter century witnessed significant population growth, aging, and major changes in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) epidemiology. Here, we used the Global Burden of Disease study data and methodologies to describe the change in burden of CKD from 1990 to 2016 involving incidence, prevalence, death, and disability-adjusted-life-years (DALYs). Globally, the incidence of CKD increased by 89% to 21,328,972 (uncertainty interval 19,100,079– 23,599,380), prevalence increased by 87% to 275,929,799 (uncertainty interval 252,442,316–300,414,224), death due to CKD increased by 98% to 1,186,561 (uncertainty interval 1,150,743–1,236,564), and DALYs increased by 62% to 35,032,384 (uncertainty interval 32,622,073–37,954,350). Measures of burden varied substantially by level of development and geography. Decomposition analyses showed that the increase in CKD DALYs was driven by population growth and aging. Globally and in most Global Burden of Disease study regions, age-standardized DALY rates decreased, except in High-income North America, Central Latin America, Oceania, Southern Sub-Saharan Africa, and Central Asia, where the increased burden of CKD due to diabetes and to a lesser extent CKD due to hypertension and other causes outpaced burden expected by demographic expansion. More of the CKD burden (63%) was in low and lower-middle-income countries. There was an inverse relationship between age-standardized CKD DALY rate and health care access and quality of care. Frontier analyses showed significant opportunities for improvement at all levels of the development spectrum. Thus, the global toll of CKD is significant, rising, and unevenly distributed; it is primarily driven by demographic expansion and in some regions a significant tide of diabetes. Opportunities exist to reduce CKD burden at all levels of development.
AB - The last quarter century witnessed significant population growth, aging, and major changes in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) epidemiology. Here, we used the Global Burden of Disease study data and methodologies to describe the change in burden of CKD from 1990 to 2016 involving incidence, prevalence, death, and disability-adjusted-life-years (DALYs). Globally, the incidence of CKD increased by 89% to 21,328,972 (uncertainty interval 19,100,079– 23,599,380), prevalence increased by 87% to 275,929,799 (uncertainty interval 252,442,316–300,414,224), death due to CKD increased by 98% to 1,186,561 (uncertainty interval 1,150,743–1,236,564), and DALYs increased by 62% to 35,032,384 (uncertainty interval 32,622,073–37,954,350). Measures of burden varied substantially by level of development and geography. Decomposition analyses showed that the increase in CKD DALYs was driven by population growth and aging. Globally and in most Global Burden of Disease study regions, age-standardized DALY rates decreased, except in High-income North America, Central Latin America, Oceania, Southern Sub-Saharan Africa, and Central Asia, where the increased burden of CKD due to diabetes and to a lesser extent CKD due to hypertension and other causes outpaced burden expected by demographic expansion. More of the CKD burden (63%) was in low and lower-middle-income countries. There was an inverse relationship between age-standardized CKD DALY rate and health care access and quality of care. Frontier analyses showed significant opportunities for improvement at all levels of the development spectrum. Thus, the global toll of CKD is significant, rising, and unevenly distributed; it is primarily driven by demographic expansion and in some regions a significant tide of diabetes. Opportunities exist to reduce CKD burden at all levels of development.
KW - CKD burden
KW - DALYs
KW - age
KW - chronic kidney disease
KW - death
KW - diabetes
KW - epidemiology
KW - global health
KW - glomerulonephritis
KW - hypertension
KW - incidence
KW - population
KW - prevalence
UR - http://www.scopus.com/inward/record.url?scp=85049442511&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2018.04.011
DO - 10.1016/j.kint.2018.04.011
M3 - Article
C2 - 30078514
AN - SCOPUS:85049442511
SN - 0085-2538
VL - 94
SP - 567
EP - 581
JO - Kidney International
JF - Kidney International
IS - 3
ER -